Diligence memo · auto-generated · as of July 3, 2026

Bolder Surgical Holdings, Inc.

Bolder Surgical Holdings, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Bolder Surgical Holdings, Inc. operates in Medical Devices, based in LOUISVILLE.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Bolder Surgical Holdings, Inc. has raised $18M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).

Largest single filing: $18M on 2018-12-12.

Most recent recorded round closed around 2020-12-18.

Valuation (modeled)modeled

Provath models Bolder Surgical Holdings, Inc. at approximately $5.1M (range $506K–$18M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.01× the median modeled value of Series B Medical Devices companies in 2019–2021 (10 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 12 months.

Last raise 5.5 yr ago; this sector typically re-raises about every 16 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 87% of Medical Devices peers (233 compared).

Modeled value ranks above 37% of those peers.

Closest niche peers: Envision Diagnostics, Inc., Onkos Surgical, Inc., Regent Surgical Health Topco, L.P., Specific Diagnostics, Inc., Covenant Surgical Holdings L.P..

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.